New York University's independent student newspaper, established in 1973.

Washington Square News

New York University's independent student newspaper, established in 1973.

Washington Square News

New York University's independent student newspaper, established in 1973.

Washington Square News

The new Merck COVID-19 treatment pill is currently awaiting FDA approval. Though the pill is effective at treating early-stage COVID patients, vaccines are still our best chance at ending the pandemic. (Staff Illustration by Manasa Gudavalli)

Opinion: The COVID-19 vaccines remain the best weapons against the pandemic

A new antiviral medication developed by Merck is awaiting FDA approval. The potential approval and widespread use of this new medication could help save thousands of lives, but the vaccine remains the best deterrent to the pandemic. 
Srishti Bungle, Deputy Opinion Editor October 19, 2021

On October 11th, the pharmaceutical company Merck requested that U.S. regulators approve their pill for use in treating COVID-19. Merck’s antiviral pill, named molnupiravir,...

Despite the recent FDA-approved rollout of three coronavirus vaccines, vaccines are still highly limited to many New Yorkers. NYU Langone Medical Center offers vaccination eligibility to a limited number of its staff and students. (Illustration by Qashka Rulino)

Securing the coveted vaccine: How NYU fights back

After just over a year of the first confirmed COVID-19 death in New York City, vaccines are available, though access is limited. These are the stories of two fortunate NYU members who were able to secure the vaccine.
Sarah Gil, Staff Writer March 15, 2021

Despite the recent FDA-approved emergency rollout of three coronavirus vaccines, New Yorkers still deal with eligibility and limited appointments, making large-scale vaccination...